This 60-minute webinar is intended for communities, providers, policy makers and advocates for PrEP, HIV prevention and HIV testing. We will provide an overview of the key takeaways and new guidance from newly released Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis.
Thursday 28 August 2025 at 13:00 – 14:00 Geneva-time
Times in your location: 6:00 EST / 7:00 EDT / 12:00 WAT / 13:00 CEST / 13:00 SAST / 14:00 EEST / 16:30 IST / 18:00 ICT / 19:00 PHST
After registering, you will receive a confirmation email containing information about joining the webinar.
This is the first webinar in a three-part series:
- Part 2 on 4 September 2025 focus on HIV testing (in partnership with PSI)
- Part 3 will focus on e-training for PrEP providers (in partnership with Jhpiego)
Further details about these webinars will be shared soon!
